These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9854584
1. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids. Kirshbom PM, Kherani AR, Onaitis MW, Feldman JM, Tyler DS. Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584 [Abstract] [Full Text] [Related]
2. Gastrointestinal carcinoids: characterization by site of origin and hormone production. Onaitis MW, Kirshbom PM, Hayward TZ, Quayle FJ, Feldman JM, Seigler HF, Tyler DS. Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653 [Abstract] [Full Text] [Related]
3. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909 [Abstract] [Full Text] [Related]
4. Gastrointestinal carcinoid tumors: factors that predict outcome. Van Gompel JJ, Sippel RS, Warner TF, Chen H. World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141 [Abstract] [Full Text] [Related]
5. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Jaffee IM, Rahmani M, Singhal MG, Younes M. Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195 [Abstract] [Full Text] [Related]
6. Developments in diagnosis and treatment of metastatic midgut carcinoid tumors. A review. Taal BG, Smits M. Minerva Gastroenterol Dietol; 2005 Dec; 51(4):335-44. PubMed ID: 16282961 [Abstract] [Full Text] [Related]
7. Foregut carcinoids: a clinical and biochemical analysis. Kirshbom PM, Kherani AR, Onaitis MW, Hata A, Kehoe TE, Feldman C, Feldman JM, Tyler DS. Surgery; 1999 Dec; 126(6):1105-10. PubMed ID: 10598194 [Abstract] [Full Text] [Related]
8. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. Perez EA, Koniaris LG, Snell SE, Gutierrez JC, Sumner WE, Lee DJ, Hodgson NC, Livingstone AS, Franceschi D. World J Surg; 2007 May; 31(5):1022-30. PubMed ID: 17429568 [Abstract] [Full Text] [Related]
9. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Kytölä S, Höög A, Nord B, Cedermark B, Frisk T, Larsson C, Kjellman M. Am J Pathol; 2001 May; 158(5):1803-8. PubMed ID: 11337378 [Abstract] [Full Text] [Related]
10. Neuroendocrine tumors of the gastrointestinal tract. Chejfec G, Falkmer S, Askensten U, Grimelius L, Gould VE. Pathol Res Pract; 1988 Apr; 183(2):143-54. PubMed ID: 3290866 [Abstract] [Full Text] [Related]
11. [Current concepts on diagnosis and treatment of carcinoid]. Krysiak R, Okopień B, Herman ZS. Przegl Lek; 2007 Apr; 64(2):103-10. PubMed ID: 17892042 [Abstract] [Full Text] [Related]
12. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M. Hepatogastroenterology; 2005 Apr; 52(63):731-41. PubMed ID: 15966194 [Abstract] [Full Text] [Related]